Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by pabalooon May 04, 2020 11:21am

70 Views

Post# 30983555

RE:RE:Pennypincher

Don't hold back Pincher it's the first thing you said that's true. I try to find companies that have been set on fire and enjoy the royalties that others have left in the fire. Often I'm left shifting through the ashes trying to find my lown lost wallet. This company and its leadership have enjoyed quite a blaze even over the short time I have owned it. Over the last month I have tripled my investment and could be left bitter soon if we don't see any future. I have looked at the remaining assets and I'm hopeful there worth 1.50-2.00 in the fire sale. If by Christmas that sale hasn't happened I will be gone and probably my money here as well. You know why rich people don't buy penny stocks?

Bullboard Posts

Understanding tax loss season and the “Santa Claus rally”